While in the mother’s womb, babies are enclosed in a fluid-filled pouch. The material that forms the walls of the sac is the amniotic membrane. As soon as a woman’s water breaks as she goes into labor, this sac is shattered, and the water that drips out is the amniotic fluid. Subsequent to childbirth, the amniotic membrane and fluid can be collected, purified, and treated into a variability of tissue-based products. Unfortunately, these amniotic membrane and fluid-based products are presently being pitched and distributed to doctors as amniotic “stem cell” products.

Adroit Market Research study on the global market for amniotic products offers a holistic view of the industry, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2020 and a projection from 2021 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global amniotic products market have been analyzed in depth.

Amniotic stem cells (ASCs) can mature into lots of different types of tissues for instance skin, cardiac, nerves, cartilage, muscle, and bone. Subsequently, ASCs have been associated to offer many potential medical applications, particularly in organ and joint regeneration. ASCs can be dig out from the amniotic sac by a procedure named amniocentesis. This procedure can take place without harming the evolving fetus, which is very imperative to highlight because of the negative stigma about embryonic derived stem cells. It is alleged owing to media exaggerating that all stem cells are resultant from slaying or deconstructing embryos, and this is merely no longer the case. Several types of stem cells have been recognized that can be isolated devoid of harming an embryo for instance hematopoietic stem cells from bone marrow, unbiblical chords or even peripheral blood or stem cells isolated from adipose tissues.

The key players of global amniotic products market report include MiMedx, Organogenesis Inc., Smith & Nephew, Integra LifeSciences Corporation, Wright Medical Group N.V., Stryker, APPLIED BIOLOGICS., Lucina BioSciences, Katena Products. Inc., Next Biosciences, among others.

Key Segments of the Global Amniotic Products Market

Type Overview, 2018-2028 (USD Million)

• Amniotic Membranes
• Amniotic Suspensions

Application Overview, 2018-2028 (USD Million)

• Wound Care
• Orthopedics
• Ophthalmology
• Other Applications

End User Overview, 2018-2028 (USD Million)

• Hospitals & ASCs
• Other End Users

Regional Overview, 2018-2028 (USD Million)

North America

• U.S.
• Canada

Europe

• UK
• Germany
• France
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Middle East and Africa

• GCC
• South Africa
• Rest of Middle East and Africa

South America

• Brazil
• Mexico
• Rest of South America